Background:
Nearly 2 million new HIV infections occur each year from sexual transmission, yet little is known about the anatomic steps that lead to systemic dissemination following vaginal exposure. We previously showed that following SIV vaginal challenge, CD4+ T-cell density increases in the female genital tract (FGT), and that local viral replication in FGT necessarily precedes dissemination. We hypothesize that cells harboring infectious virus are the predominant mechanism of viral dissemination.
Methods:
To address this, we vaginally challenged eight rhesus macaques (RM) with the sequence tagged synthetic swarm SIVmac239X. Six animals were pre-treated with fingolimod (FTY720) to block the egress of leucocytes out of tissues. Animals were euthanized two weeks post-challenge. Plasma viral load was monitored frequently, and sequence analysis was used to assess the number of transmitted/founder lineages. T-cell populations were assessed using flow cytometry and immunohistochemistry.
Results:
We observed a significant delay in the time to measurable viremia in animals receiving fingolimod (up to 5 days) as well as a drastic reduction in viral load magnitude at the time of necropsy (up to 5 logs). We observed a striking reduction in the number of CD4+T cells (and all leucocytes) in the blood following fingolimod treatment with an abundance of CD4+T cells retained in lymph nodes. However, when quantifying the density of CD4+T cells within the FGT, there was no significant difference in treated vs non-treated animals. In contrast, CD8+T cells were more abundant in the vagina tissue of non-treated animals. Sequencing of plasma virus revealed that animals treated with fingolimod were systemically infected with only one to two different variants, whereas the non-treated animals were infected with an average of five distinct variants.
Conclusions:
Restricting trafficking of CD4+ T cells impeded the transition of local infection to systemic infection as demonstrated by significantly decreased and delayed plasma viremia. These differences were not due to differences in the availability of target cells at the challenge site nor were they likely due to any potential adaptive immune effects prior to dissemination. These observations highlight the importance of the mobility of productively infected cells and that systemic spread of virus via cell-free virion dissemination is slower and less efficient.